Orgalutran 0.25mg Injection
Marketer
Organon (India) Ltd
Salt Composition
Ganirelix (0.25mg)
Overview Orgalutran 0.25mg Injection
Orgalutran 0.25mg Injection, a gonadotropin-releasing hormone antagonist, assists in female infertility treatment. It prevents premature egg release, delaying ovulation. Administered subcutaneously by a healthcare professional, self-injection is strictly prohibited. Your doctor or nurse will provide guidance on proper at-home injection technique. Dosage and frequency are determined by your individual needs and will be prescribed by your physician to manage your condition. Continue treatment as directed. Common side effects may include injection site reactions (such as redness, itching, or inflammation), vaginal bleeding, and nausea. Rotating injection sites daily can minimize irritation. Report dizziness, fainting, abdominal pain, or vomiting immediately. Prior to commencing treatment, disclose any history of liver or kidney disease, or breastfeeding, to your physician. Additionally, inform your doctor of all other medications you are currently using, as interactions may affect Orgalutran's efficacy.
Primary Ingredients of Orgalutran 0.25mg Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Orgalutran 0.25mg Injection
Inability to conceive in women
Major Benefits of Orgalutran 0.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Orgalutran 0.25mg Injection:
- Injection site reaction
- Headache
- Nausea
- Ovarian hyperstimulation syndrome
- Abdominal pain
- Vaginal bleeding
How to use Orgalutran 0.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Orgalutran 0.25mg Injection works:
Infertility treatments in women may be complicated by premature egg release before the eggs are mature enough for fertilization. Orgalutran 0.25mg Injection counteracts a natural hormone, thereby preventing this premature ovarian release of eggs.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Orgalutran 0.25mg Injection requires careful consideration. Seek medical advice before combining them.
PregnancyUNSAFE
The use of Orgalutran 0.25mg Injection is strongly contraindicated during pregnancy. Pregnant women should consult their physician, as research in both animals and humans indicates substantial adverse effects on fetal development.
Breast feedingUNSAFE
Administration of Orgalutran 0.25mg Injection is contraindicated during lactation. Evidence indicates potential infant toxicity from this medication.
DrivingCONSULT YOUR DOCTOR
The effect of Orgalutran 0.25mg Injection on driving ability is undetermined. Refrain from driving if you encounter any symptoms impairing concentration or reaction time.
KidneyCAUTION
Ganirelix 0.25mg Injection requires careful administration in individuals with impaired renal function. Dosage modification of Ganirelix 0.25mg Injection may be necessary. Physician consultation is recommended. Ganirelix 0.25mg Injection is contraindicated in patients exhibiting moderate to severe kidney disease.
LiverCAUTION
Ganirelix 0.25mg Injection requires careful administration in individuals with hepatic impairment. Dosage modification of Ganirelix 0.25mg Injection may be necessary. Physician consultation is recommended. Ganirelix 0.25mg Injection is contraindicated in patients exhibiting moderate to severe liver dysfunction.
What if you forget to take Orgalutran 0.25mg Injection :
NA
Facts to Know About Orgalutran 0.25mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Peptide chains |
| Developing Habits | No. |
| Treatment Category | Endocrine Signals |
| Action Class | GnRH receptor antagonists |
3,018 People bought this recently